Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Other Long Term Assets : $2,579 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Takeda Pharmaceutical Co Other Long Term Assets?

Takeda Pharmaceutical Co's other long-term assets for the quarter that ended in Dec. 2023 was $2,579 Mil.

Takeda Pharmaceutical Co's quarterly other long-term assets declined from Jun. 2023 ($3,082 Mil) to Sep. 2023 ($2,678 Mil) but then stayed the same from Sep. 2023 ($2,678 Mil) to Dec. 2023 ($2,579 Mil).

Takeda Pharmaceutical Co's annual other long-term assets declined from Mar. 2021 ($4,178 Mil) to Mar. 2022 ($3,754 Mil) and declined from Mar. 2022 ($3,754 Mil) to Mar. 2023 ($3,212 Mil).

Takeda Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Takeda Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Other Long Term Assets Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

1,587.69

3,826.12

4,177.68

3,754.08

3,211.99

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															3,158.79	3,211.99	3,081.99	2,677.70	2,579.44

Takeda Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

TAK:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.